Jonie Ing Kondracki
Partner
Jonie Kondracki is a partner in the San Francisco office of Wilson Sonsini Goodrich & Rosati, where her practice focuses on capital markets transactions and general corporate and securities matters.
She represents companies through all stages of growth, from private companies to established public companies, as well as investment banks and investors. Jonie has advised clients on a wide range of transactions, including initial public offerings, follow-on and secondary offerings, private placements, tender offers, direct listings, and debt offerings, with significant experience in the technology and life sciences industries. She also counsels clients on corporate governance, reporting obligations, and other compliance matters.
Prior to joining Wilson Sonsini, Jonie was a partner in the San Francisco office of Cooley LLP.
Experience
Jonie Kondracki is a partner in the San Francisco office of Wilson Sonsini Goodrich & Rosati, where her practice focuses on capital markets transactions and general corporate and securities matters.
She represents companies through all stages of growth, from private companies to established public companies, as well as investment banks and investors. Jonie has advised clients on a wide range of transactions, including initial public offerings, follow-on and secondary offerings, private placements, tender offers, direct listings, and debt offerings, with significant experience in the technology and life sciences industries. She also counsels clients on corporate governance, reporting obligations, and other compliance matters.
Prior to joining Wilson Sonsini, Jonie was a partner in the San Francisco office of Cooley LLP.
Education
- J.D., University of Pennsylvania Carey Law School, 2007
Cum Laude
- B.A., University of California, Berkeley, 2002
Honors
- Recognized in the 2022-2026 editions of Chambers Global for USA Capital Markets: Debt & Equity: Western United States
- Recognized in the 2021-2026 editions of Chambers USA for California Capital Markets: Debt & Equity
- Recognized in the 2021-2026 editions of Chambers USA for Nationwide Western United States Capital Markets: Debt & Equity
Admissions
- State Bar of California
Credentials
Education
- J.D., University of Pennsylvania Carey Law School, 2007
Cum Laude
- B.A., University of California, Berkeley, 2002
Honors
- Recognized in the 2022-2026 editions of Chambers Global for USA Capital Markets: Debt & Equity: Western United States
- Recognized in the 2021-2026 editions of Chambers USA for California Capital Markets: Debt & Equity
- Recognized in the 2021-2026 editions of Chambers USA for Nationwide Western United States Capital Markets: Debt & Equity
Admissions
- State Bar of California
Select representations include:
- Lightspeed Venture Partners in the initial public offering of Netskope*
- Goldman Sachs & Co. LLC and Morgan Stanley in the convertible notes offering of Etsy*
- Unity Software in its initial public offering and convertible notes offerings and on general corporate and securities matters*
- Instacart in its initial public offering and on general corporate and securities matters*
- PagerDuty on general corporate and securities matters
- Noom on general corporate and securities matters*
- Attentive Mobile on general corporate and securities matters*
- Quora on general corporate and securities matters*
- Surrozen on general corporate and securities matters*
- Origin Materials on general corporate and securities matters*
- Annexon Biosciences in its follow-on offering*
- Geron Corporation in its follow-on offering*
- Goldman Sachs & Co. LLC, Morgan Stanley, and TD Cowen in the initial public offering of Cue Health*
- LegalZoom in its initial public offering*
- J.P. Morgan, TD Cowen, and Piper Sandler in the initial public offering and follow-on offerings of Day One Biopharmaceuticals*
- J.P. Morgan, Jefferies, and TD Cowen in the initial public offering and the underwriters in follow-on offerings of Biomea Fusion*
- BofA Securities, Credit Suisse, and Piper Sandler in the initial public offering of Angion Biomedica*
- Goldman Sachs & Co. LLC, Leerink Partners, and Piper Sandler in the initial public offering and follow-on offerings of Kinnate Biopharma*
- BofA Securities, Leerink Partners, and RBC Capital Markets in the initial public offering and the underwriters in follow-on offerings of 89bio*
- Goldman Sachs & Co. LLC, Jefferies, and Evercore ISI in the initial public offering and follow-on offerings of Phathom Pharmaceuticals*
- Jefferies, Piper Sandler, and Stifel in the initial public offering and follow-on offerings of IGM Biosciences*
- Harpoon Therapeutics in its initial public offering and follow-on offerings*
- Goldman Sachs & Co. LLC, J.P. Morgan, BofA Securities, and Barclays in the initial public offering of CrowdStrike*
- Citigroup, Goldman Sachs & Co. LLC, and Leerink Partners in the initial public offering and follow-on offerings of Arcus Biosciences*
- BofA Securities and TD Cowen in the initial public offering and follow-on offerings of Audentes Therapeutics*
- BofA Securities and Piper Sandler in the follow-on offering of Inotek Pharmaceuticals*
- Jefferies and RBC Capital Markets in the follow-on offering of Gemphire Therapeutics*
- Jefferies and Wells Fargo Securities in the initial public offering and follow-on and secondary offerings of Xenon Pharmaceuticals*
- Credit Suisse, BofA Securities, and Raymond James in the initial public offering of Ooma*
- J.P. Morgan, Morgan Stanley, Leerink Partners, and UBS Investment Bank in the initial public offering and the underwriters in follow-on offerings of Ascendis Pharma*
- New Relic in its initial public offering*
- Goldman Sachs & Co. LLC and Morgan Stanley in the initial public offering and convertible notes offering of Zendesk*
- Morgan Stanley, J.P. Morgan, and BofA Securities in the secondary offering of LinkedIn*
*Denotes experience at another firm prior to joining Wilson Sonsini in 2025.
Matters
Select representations include:
- Lightspeed Venture Partners in the initial public offering of Netskope*
- Goldman Sachs & Co. LLC and Morgan Stanley in the convertible notes offering of Etsy*
- Unity Software in its initial public offering and convertible notes offerings and on general corporate and securities matters*
- Instacart in its initial public offering and on general corporate and securities matters*
- PagerDuty on general corporate and securities matters
- Noom on general corporate and securities matters*
- Attentive Mobile on general corporate and securities matters*
- Quora on general corporate and securities matters*
- Surrozen on general corporate and securities matters*
- Origin Materials on general corporate and securities matters*
- Annexon Biosciences in its follow-on offering*
- Geron Corporation in its follow-on offering*
- Goldman Sachs & Co. LLC, Morgan Stanley, and TD Cowen in the initial public offering of Cue Health*
- LegalZoom in its initial public offering*
- J.P. Morgan, TD Cowen, and Piper Sandler in the initial public offering and follow-on offerings of Day One Biopharmaceuticals*
- J.P. Morgan, Jefferies, and TD Cowen in the initial public offering and the underwriters in follow-on offerings of Biomea Fusion*
- BofA Securities, Credit Suisse, and Piper Sandler in the initial public offering of Angion Biomedica*
- Goldman Sachs & Co. LLC, Leerink Partners, and Piper Sandler in the initial public offering and follow-on offerings of Kinnate Biopharma*
- BofA Securities, Leerink Partners, and RBC Capital Markets in the initial public offering and the underwriters in follow-on offerings of 89bio*
- Goldman Sachs & Co. LLC, Jefferies, and Evercore ISI in the initial public offering and follow-on offerings of Phathom Pharmaceuticals*
- Jefferies, Piper Sandler, and Stifel in the initial public offering and follow-on offerings of IGM Biosciences*
- Harpoon Therapeutics in its initial public offering and follow-on offerings*
- Goldman Sachs & Co. LLC, J.P. Morgan, BofA Securities, and Barclays in the initial public offering of CrowdStrike*
- Citigroup, Goldman Sachs & Co. LLC, and Leerink Partners in the initial public offering and follow-on offerings of Arcus Biosciences*
- BofA Securities and TD Cowen in the initial public offering and follow-on offerings of Audentes Therapeutics*
- BofA Securities and Piper Sandler in the follow-on offering of Inotek Pharmaceuticals*
- Jefferies and RBC Capital Markets in the follow-on offering of Gemphire Therapeutics*
- Jefferies and Wells Fargo Securities in the initial public offering and follow-on and secondary offerings of Xenon Pharmaceuticals*
- Credit Suisse, BofA Securities, and Raymond James in the initial public offering of Ooma*
- J.P. Morgan, Morgan Stanley, Leerink Partners, and UBS Investment Bank in the initial public offering and the underwriters in follow-on offerings of Ascendis Pharma*
- New Relic in its initial public offering*
- Goldman Sachs & Co. LLC and Morgan Stanley in the initial public offering and convertible notes offering of Zendesk*
- Morgan Stanley, J.P. Morgan, and BofA Securities in the secondary offering of LinkedIn*
*Denotes experience at another firm prior to joining Wilson Sonsini in 2025.
Select Speaking Engagements
- Roundtable Co-lead, “IPO Readiness Decisions Legal Leaders Underestimate,” The L Suite 2026 TechGC Unicorn Offsite, March 10-12, 2026
Insights
Select Speaking Engagements
- Roundtable Co-lead, “IPO Readiness Decisions Legal Leaders Underestimate,” The L Suite 2026 TechGC Unicorn Offsite, March 10-12, 2026
Recent Insights
News Articles
Wilson Sonsini Practices, Attorneys Recognized in 2026 Chambers USA Guide
The 2026 Chambers USA guide has recognized Wilson Sonsini Goodrich & Rosati as a leading law firm in 44 geography-specific practice categories and named 87 Wilson Sonsini attorneys among the best in their fields. This year, the firm received four new practice area rankings, including in the nationwide National Security and Capital Markets: Convertible Debt categories, and three improved practice area rankings.
Learn More
Press Releases
Wilson Sonsini Expands Corporate and Securities Practice with the Addition of Jonie Ing Kondracki
SAN FRANCISCO, CA – October 21, 2025 – Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, today announced that Jonie Ing Kondracki has joined the firm as a partner in its Corporate Department in San Francisco. Kondracki advises companies, investment banks, and investors on capital markets transactions and general corporate and securities matters.
Learn More
- Privacy Policy
- Terms of Use
- Accessibility
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.